COPPSERS
CLDI icon

Commonwealth of Pennsylvania Public School Employees Retirement System’s Calidi Biotherapeutics CLDI Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7
Closed -$141K – 1628
2023
Q2 		$141K Hold
7
– – ﹤0.01% 1645
2023
Q1 		$138K Hold
7
– – ﹤0.01% 1713
2022
Q4 		$136K Buy
+7
New +$134K ﹤0.01% 1764

Other funds holding CLDI

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $360M AUM 19.03% 1-Year Est. Return
RWI
Red Wave Investments Dillsburg, Pennsylvania $394M AUM 20.27% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's CLDI Position: Q3 2023 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of Calidi Biotherapeutics (CLDI) in Q3 2023, closing a stake of 7 shares — an estimated $141K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in CLDI in Q4 2022 and held it in 3 quarters. The position peaked at $141K in Q2 2023. 10 funds tracked by Wall St. Rank hold CLDI as of Q3 2023.

  • Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining Calidi Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 7 Calidi Biotherapeutics shares in Q3 2023, an estimated $141K.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Calidi Biotherapeutics in Q4 2022 and held it in 3 quarters.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's Calidi Biotherapeutics position peaked at $141K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2023.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q3 2023, filed 9 Nov 2023.